Oral anticoagulation in very elderly patients with atrial fibrillation: A nationwide cohort study

Keyphrases

• National Cohort Study 100%
• Atrial Fibrillation 100%
• Oral Anticoagulation 100%
• Super-elderly Patient 100%
• Intracranial Hemorrhage 88%
• Warfarin 77%
• Risk of Ischemic Stroke 66%
• Confidence Interval 44%
• Hazard Ratio 44%
• Vitamin K Antagonists 44%
• Low Risk 33%
• Oral Anticoagulants 33%
• Net Clinical Benefit 33%
• Taiwan 22%
• Risk Model 22%
• Stroke Risk 22%
• Antithrombotic Therapy 22%
• National Health Insurance Research Database (NHIRD) 11%
• 3-group 11%
• Number of Events 11%
• Elderly Patients 11%
• Number of Patients 11%
• Stroke Event 11%
• Antiplatelet Agents 11%
• Stroke Prevention 11%
• Non-vitamin K Antagonist Oral Anticoagulants 11%
• Hemorrhage Risk 11%
• Competing Risk Analysis 11%
• Non-treatment 11%
• Antiplatelet Drugs 11%
• Thromboprophylaxis 11%
• Oral Anticoagulant Therapy 11%

Pharmacology, Toxicology and Pharmaceutical Science

• Atrial Fibrillation 100%
• Cohort Study 100%
• Brain Hemorrhage 88%
• Warfarin 77%
• Brain Ischemia 66%
• Anticoagulant Agent 55%
• Cerebrovascular Accident 33%
• Antithrombocytic Agent 22%
• Antithrombotic Therapy 22%